Project Progress Report
4.
Objectives of the proposal
i. To evaluate an Ayurvedic Treatment Protocol to bring long term remission
among migraine patients.
ii. To evaluate the efficacy in reducing the intensity and frequency of pain and
associated symptoms in migraine patients.
iii. To evaluate the Ayurveda approach in migraine patients using modern
scientific parameters.
5.
Methodology
All the chronic/refractory migraine patients, who presented to the neurology OPD,
were included in the study. Patient who failed 3-4 adequate trials of preventive
medicines, alone or in combination, from at least 2 of 4 drug classes including:
beta-lockers, anticonvulsants, tricyclics, and calcium channel blockers and those
who also failed adequate trials of abortive medicines, including both a triptan and
dihydroergotamine (DHE) intranasal or injectable formulation and either non
steroidal anti-inflammatory drugs (NSAIDs) or combination analgesic, unless
contraindicated were included.
Patients were randomized to Ayurvedic Treatment Protocol and Conventional
Treatment by random sealed opaque envelopes.
a) 6.1) Inclusion Criteria:
1. Age/sex
Male or female patient age 18-65 years
2. General health
Satisfactory
medical
assessment
with
no
clinical
significant
abnormalities except for study related disease condition
Randomized controlled clinical trial to evaluate prophylactic
3 properties of Ayu rv ed ic Treatment Protocol in
refractory and chronic migraine patients